BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33038864
Number of visits today
4838
Number of downloads
16231146
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Berkel C, Cacan E. Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer. Life Sci 2021;286:120029. [PMID: 34634322 DOI: 10.1016/j.lfs.2021.120029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Azmi AS, Mohammad RM. Deregulated transcription factors and poor clinical outcomes in cancer patients. Semin Cancer Biol 2022;86:122-34. [PMID: 35940398 DOI: 10.1016/j.semcancer.2022.08.001] [Reference Citation Analysis]
2 Chiang C, Yang H, Zhu L, Chen C, Chen C, Zuo Y, Zheng D. The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer. Front Genet 2022;13:918509. [DOI: 10.3389/fgene.2022.918509] [Reference Citation Analysis]
3 Alemohammad H, Motafakkerazad R, Asadzadeh Z, Farsad N, Hemmat N, Najafzadeh B, Vasefifar P, Baradaran B. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin. Gene 2022;821:146333. [PMID: 35182674 DOI: 10.1016/j.gene.2022.146333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yoon J, Kim H, Jeong YI, Yang HS. CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells. Int J Mol Sci 2022;23:3594. [PMID: 35408970 DOI: 10.3390/ijms23073594] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345